hemoglobin dl mg minimum patients enrollment phase weeks anemia arm 
zubrod performance registration status days prior step documented patients study 
step registration prior crossover days patients treatment mcl optional dl 
exclusion registration criteria randomization neratinib secondary intraperitoneal experiencing mucinous borderline 
step randomization prior registration ii days criteria dl enrollment hemoglobin 
